Histone deacetylase inhibitor application is lethal to many cancer types. To screen for the therapeutic potential of HDIs it is necessary to analyze their ability to target and kill cancer cells in vivo. Here, we describe the xenografting of (germ cell) cancer cell lines into the flank of nude mice and the subsequent intravenous application of HDIs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-4939-6527-4_15 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!